EW
Edwards Lifesciences Corporation · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth -4.0% ·
share flow -1.3% ·
net new positions -8.3%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 14.87M | $1.28B | n/a | n/a |
| Q2 2026 | 163 | -6 | 423.46M | $38.23B | +2 | −9 |
| Q1 2026 | 173 | +2 | 408.99M | $32.75B | +6 | −5 |
| Q4 2025 | 170 | 0 | 441.50M | $37.63B | +2 | −1 |
| Q3 2025 | 24 | -1 | 280.60M | $21.82B | +1 | −3 |
| Q2 2025 | 23 | 0 | 232.09M | $18.15B | n/a | n/a |
| Q1 2025 | 20 | -1 | 112.98M | $8.18B | n/a | −1 |
| Q4 2024 | 21 | +1 | 116.40M | $8.61B | +1 | n/a |
| Q3 2024 | 19 | +1 | 77.58M | $5.12B | +2 | −1 |
| Q2 2024 | 18 | n/a | 60.09M | $5.55B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 70.36M | +0.5% | $5.47B | 0.1% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (passive) | 54.29M | -2.4% | $4.22B | 0.1% | ▼ Trim | 2 | SEC ↗ ×22 |
| 3 | JPMorgan Chase ✦ | 50.12M | n/a | $3.90B | 0.1% | n/c | 1 | SEC ↗ ×38 |
| 4 | State Street Global Advisors ✦ (passive) | 25.62M | -0.1% | $1.99B | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 20.80M | +4.9% | $1.62B | 0.3% | ▲ Add | 6 | SEC ↗ ×9 |
| 6 | Fidelity (FMR) ✦ | 14.58M | +476.7% | $1.13B | 0.1% | ▲ Add | 2 | SEC ↗ ×5 |
| 7 | Geode Capital Management ✦ (passive) | 12.84M | +0.9% | $993.49M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Morgan Stanley ✦ | 6.51M | n/a | $506.23M | 0.0% | n/c | 1 | SEC ↗ ×20 |
| 9 | Citadel Advisors ✦ | 4.23M | -66.7% | $329.32M | 0.3% | ▼ Trim | 6 | SEC ↗ |
| 10 | Marshall Wace ✦ | 3.57M | -48.3% | $277.37M | 0.3% | ▼ Trim | 6 | SEC ↗ ×4 |
| 11 | PRIMECAP Management ✦ | 3.52M | +2.2% | $274.01M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 12 | Viking Global Investors ✦ | 3.07M | New | $238.69M | 0.6% | New | 1 | SEC ↗ |
| 13 | Goldman Sachs Group ✦ | 2.88M | n/a | $223.94M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 14 | AQR Capital Management ✦ | 2.08M | +114.5% | $161.05M | 0.1% | ▲ Add | 6 | SEC ↗ ×6 |
| 15 | Millennium Management ✦ | 1.78M | -73.4% | $138.41M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 1.36M | +55.6% | $105.73M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 858.84K | -0.1% | $66.79M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 18 | Point72 Asset Management ✦ | 732.06K | -75.9% | $56.93M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 19 | Baillie Gifford ✦ | 572.25K | -1.8% | $44.50M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 20 | Arrowstreet Capital ✦ | 281.97K | +83.2% | $21.93M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | Fisher Asset Management ✦ | 247.42K | -21.8% | $19.24M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 180.31K | -59.5% | $14.02M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 23 | Two Sigma Investments ✦ | 72.20K | +32.8% | $5.61M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 33.46K | -22.7% | $2.60M | 0.0% | ▼ Trim | 6 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Viking Global Investors | $238.69M | 0.6% |
Exited
| Norges Bank | $580.64M | was 0.1% |
| Renaissance Technologies | $81.37M | was 0.1% |
| D. E. Shaw & Co. | $13.39M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 4 holders, 229.24K shares, $319,498 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 619 sh · $53,017
Officer · 619 sh · $54,169
Officer · 544 sh · $49,534
Officer · 2.64K sh · $237,907
Officer · 1.24K sh · $113,417
Officer · 1.15K sh · $105,893
Officer · 30.65K sh · $2.79M
Officer · 619 sh · $56,967
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology